Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 51,900 shares, a drop of 35.6% from the March 31st total of 80,600 shares. Based on an average trading volume of 917,800 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company's shares are sold short.
Analyst Ratings Changes
Several brokerages have recently issued reports on RBGLY. Barclays lowered shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a report on Tuesday, February 4th. Royal Bank of Canada restated an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Three analysts have rated the stock with a hold rating, two have issued a buy rating and three have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy".
Get Our Latest Stock Report on RBGLY
Reckitt Benckiser Group Stock Up 4.3 %
Shares of RBGLY stock traded up $0.55 during trading on Friday, reaching $13.46. 2,164,280 shares of the company's stock were exchanged, compared to its average volume of 375,625. The firm's fifty day moving average price is $13.17 and its 200-day moving average price is $12.72. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a twelve month low of $10.43 and a twelve month high of $14.10.
Reckitt Benckiser Group Increases Dividend
The company also recently declared a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be paid a $0.2909 dividend. The ex-dividend date is Friday, April 11th. This is an increase from Reckitt Benckiser Group's previous dividend of $0.19.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
